Skip to main content
PSNL
NASDAQ Industrial Applications And Services

Personalis Clears HSR Antitrust Review for Tempus Merger

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$16.03
Mkt Cap
$1.712B
52W Low
$4.955
52W High
$18.89
52W Position info
224% above low
Off High info
15% below high
Rel. Volume info
1.6× avg
Market data snapshot near publication time

PSNL has more than doubled off its 52-week low of $4.955.

Summary

Personalis announced the HSR waiting period for its pending acquisition by Tempus AI expired on October 2, 2026, clearing a major antitrust condition. Stockholder approval and other closing conditions remain. The merger will proceed in two steps, with Personalis first merging into Aviary Development, Inc. and then into Toucan Development, LLC.

Updated with an SEC 425 filing · What changed

Updates

  1. · SEC 425 — The HSR waiting period for the Personalis-Tempus merger expired on October 2, 2026, satisfying a key closing condition.

    • Merger Structure — The merger is a two-step process: Merger Sub I (Aviary Development, Inc.) merges with Personalis, which survives as a direct wholly owned subsidiary of Tempus; then Personalis merges into Merger Sub II (Toucan Development, LLC), which survives as a direct wholly owned subsidiary of Tempus.
    • Regulatory Filings — Personalis and Tempus filed HSR notifications on July 31, 2026. Tempus filed a Form S-4 on August 31, 2026, and Amendment No. 1 on October 2, 2026. A Schedule 13E-3 was filed on August 31, 2026, with Amendment No. 1 on October 2, 2026.
    All 6 details
    • The merger is a two-step process: Merger Sub I merges with and into Personalis, with Personalis surviving as a direct, wholly owned subsidiary of Tempus; immediately thereafter, Personalis merges with and into Merger Sub II, with Merger Sub II surviving as a direct, wholly owned subsidiary of Tempus.
    • Personalis and Tempus each filed a Premerger Notification and Report Form under the HSR Act with the Antitrust Division of the U.S. Department of Justice and the U.S. Federal Trade Commission on July 31, 2026.
    • Tempus filed a preliminary Registration Statement on Form S-4 on August 31, 2026, and Amendment No. 1 thereto on October 2, 2026, each of which includes a proxy statement of Personalis and a prospectus of Tempus.
    • Tempus, Personalis, and certain of their respective affiliates jointly filed a Rule 13e-3 Transaction Statement on Schedule 13E-3 with the SEC on August 31, 2026, and Amendment No. 1 thereto on October 2, 2026.
    • Merger Sub I is Aviary Development, Inc., a Delaware corporation.
    • Merger Sub II is Toucan Development, LLC, a Nevada limited liability company.

Key Events · M&A and Partnerships · PSNL

  • New · · SEC 425

    Two-Step Merger Structure

    The merger is a two-step process: Merger Sub I merges with and into Personalis, with Personalis surviving as a direct, wholly owned subsidiary of Tempus; immediately thereafter, Personalis merges with and into Merger Sub II, with Merger Sub II surviving as a direct, wholly owned subsidiary of Tempus. Merger Sub I is Aviary Development, Inc., a Delaware corporation, and Merger Sub II is Toucan Development, LLC, a Nevada limited liability company.

  • New · · SEC 425

    HSR Filings Made

    Personalis and Tempus each filed a Premerger Notification and Report Form under the HSR Act with the Antitrust Division of the U.S. Department of Justice and the U.S. Federal Trade Commission on July 31, 2026.

  • New · · SEC 425

    S-4 Registration Statement Filed

    Tempus filed a preliminary Registration Statement on Form S-4 on August 31, 2026, and Amendment No. 1 thereto on October 2, 2026, each of which includes a proxy statement of Personalis and a prospectus of Tempus.

  • New · · SEC 425

    Schedule 13E-3 Filed

    Tempus, Personalis, and certain of their respective affiliates jointly filed a Rule 13e-3 Transaction Statement on Schedule 13E-3 with the SEC on August 31, 2026, and Amendment No. 1 thereto on October 2, 2026.

  • Updated · · SEC 425

    HSR Waiting Period Expired

    The Hart-Scott-Rodino antitrust waiting period for the Tempus AI merger expired at 11:59 p.m. Eastern time on October 2, 2026, clearing a key regulatory condition to closing.

  • Refiling Restarted Clock

    Tempus voluntarily withdrew its HSR filing on August 31, 2026 and refiled on September 2, 2026, restarting the 30-day statutory waiting period that has now lapsed without a second request.

  • Remaining Closing Conditions

    The merger still requires Personalis stockholder approval at a virtual special meeting (date to be announced) and satisfaction or waiver of other conditions in the Merger Agreement.

  • Deal Terms Recap

    The transaction values Personalis at approximately $1.85 billion, with Tempus AI acquiring the company in an all-stock deal announced July 20, 2026.


Analysis · PSNL · Industrial Applications And Services

The HSR waiting period expired on October 2, 2026, removing a key regulatory hurdle to the $1.85 billion Tempus acquisition. The deal still requires Personalis stockholder approval and satisfaction of other closing conditions, but antitrust clearance materially de-risks the transaction. The refiling on September 2, 2026 restarted the clock, and the expiration now confirms no second request from regulators. The merger is structured as a two-step process: Merger Sub I, Aviary Development, Inc., a Delaware corporation, will merge with and into Personalis, with Personalis surviving as a direct, wholly owned subsidiary of Tempus; immediately thereafter, Personalis will merge with and into Merger Sub II, Toucan Development, LLC, a Nevada limited liability company, with Merger Sub II surviving as a direct, wholly owned subsidiary of Tempus. Personalis and Tempus each filed a Premerger Notification and Report Form under the HSR Act with the Antitrust Division of the U.S. Department of Justice and the U.S. Federal Trade Commission on July 31, 2026. Tempus filed a preliminary Registration Statement on Form S-4 on August 31, 2026, and Amendment No. 1 thereto on October 2, 2026, each of which includes a proxy statement of Personalis and a prospectus of Tempus. Tempus, Personalis, and certain of their respective affiliates jointly filed a Rule 13e-3 Transaction Statement on Schedule 13E-3 with the SEC on August 31, 2026, and Amendment No. 1 thereto on October 2, 2026.

How filings like this one have moved

In the 30 days to Oct 7, 2026, 29% of the 1648 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.62%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PSNL was trading at $16.03 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.7B. The 52-week trading range was $4.96 to $18.89. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PSNL - Latest Insights

PSNL
Aug 31, 2026, 5:20 PM EDT
Filing Type: SC 13E3
Importance Score:
8
Price at Filing: $16.70
Real-time Price: $15.97 info
Change: -$0.730 (-4%) info
Market Cap: $1.712B info
PSNL
Aug 04, 2026, 4:11 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $13.29
Real-time Price: $15.97 info
Change: +$2.68 (+20%) info
Market Cap: $1.712B info
PSNL
Jul 20, 2026, 5:26 PM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $13.30
Real-time Price: $15.97 info
Change: +$2.67 (+20%) info
Market Cap: $1.712B info
PSNL
Jul 20, 2026, 9:19 AM EDT
Filing Type: 425
Importance Score:
10
Price at Filing: $14.43
Real-time Price: $15.97 info
Change: +$1.54 (+11%) info
Market Cap: $1.712B info
PSNL
Jul 20, 2026, 9:18 AM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $14.43
Real-time Price: $15.97 info
Change: +$1.54 (+11%) info
Market Cap: $1.712B info